Leiomyoma. Leiomyoma of uterus
Conditions
Interventions
Intervention 1: Intervention: From the first day of menstruation, using of Royan vaginal cream full 3 applicator per night for 2 periods. Intervention 2: Control: From the first day of menstruation,
Treatment - Drugs
Intervention: From the first day of menstruation, using of Royan vaginal cream full 3 applicator per night for 2 periods.
Control: From the first day of menstruation, using of Placebo vaginal cream full 3 applicator per night for 2 periods.
Sponsors
Ardabil University of Medical Sciences.
Bu Ali Company of Drugs Production
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : All women of childbearing age (45 to 18) with at least one Fybrm to1 cm or larger, which is confirmed by ultrasound. Have a negative pregnancy test. Exclusion criteria : 1. Patients who have had hormone therapy 6 months before the treatment. 2. Patients who have had surgeries before, such as: Myomectomy. 3. Requires immediate surgical. 4. Pregnancy during the treatment 5.Abnormal Pap-Asmyr or severe anemia (8/0 )
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in bleeding volume of Myoma. Timepoint: Before and after treatment. Method of measurement: Submit in Higam table. | — |
Secondary
| Measure | Time frame |
|---|---|
| The pain of Myoma. Timepoint: Before and after intervention. Method of measurement: VAS measurement.;Size of the Myoma. Timepoint: Before and after intervention. Method of measurement: Sonography.;Life style. Timepoint: Before and after intervention. Method of measurement: Questionnaire Code SF36. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSousan Houshmandi
Ardabil University of Medical Sciences
Outcome results
None listed